1)You add a drug to cells that can pass through hydrophilic or hydrobic environments (e.g., membranes & cytosol). The drug specifically prevents the binding of KDEL (ER retention signal) to

1)You add a drug to cells that can pass through hydrophilic or hydrobic environments (e.g., membranes & cytosol). The drug specifically prevents the binding of KDEL (ER retention signal) to any other molecules. In the short term, what would happen to the synthesis and localization of translocon proteins?

a. New complete translocon proteins would be made, but they would end up in the golgi apparatus.

b. New complete translocon proteins would be made, but they would end up at the plasma membrane

c. No new intact translocon proteins would be synthesized

d. New complete translocon proteins would be made, but they would be secreted

e. New complete translocon proteins would be made and localized normally